Amphastar pharmaceuticals announces pricing of offering of $300.0 million of convertible senior notes

Rancho cucamonga, ca / accesswire / september 13, 2023 / amphastar pharmaceuticals, inc. (nasdaq:amph) ("amphastar") today announced the pricing of $300.0 million aggregate principal amount of 2.00% convertible senior notes due 2029 (the "notes") in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the "securities act"). amphastar also granted the initial purchasers of the notes an option to purchase up to an additional $45.0 million aggregate principal amount of the notes.
AMPH Ratings Summary
AMPH Quant Ranking